English
Structure via PubChem · Public domain (PubChem)
tesaglitazar
Sign in to saveTesaglitazar (also known as AZ 242) is a dual peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, proposed for the management of type 2 diabetes.
Chemical data
- Formula
- C20H24O7S
- Molecular weight
- 408.5 g/mol
- IUPAC name
- (2S)-2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 3
- Molecule type
- Small molecule
- Indications
- type 2 diabetes mellitus
via ChEMBL · EBI
Wikidata facts
- Subclass of
- carboxylic acid
- Mass
- 408.124
Show 4 more facts
- chemical formula
- C₂₀H₂₄O₇S
- isomeric SMILES
- CCO[C@@H](CC1=CC=C(C=C1)OCCC2=CC=C(C=C2)OS(=O)(=O)C)C(=O)O
- canonical SMILES
- CCOC(CC1=CC=C(C=C1)OCCC2=CC=C(C=C2)OS(=O)(=O)C)C(=O)O
- Commons category
- Tesaglitazar
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Tesaglitazar (also known as AZ 242) is a dual peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, proposed for the management of type 2 diabetes.
The drug had completed several phase III clinical trials, however in May, 2006 AstraZeneca announced that it had discontinued further development.
Excerpted from Wikipedia’s “tesaglitazar” article, available under the CC BY-SA 4.0 licence.